FLOW CYTOMETRY & HIGH THROUGHPUT SCREENING SHARED RESOURCE ABSTRACT The UNMCC Flow Cytometry and High Throughput Screening Shared Resource (Flow Cytometry-HTS) provides UNMCC and other researchers with state-of-the-art instruments, infrastructure and expertise. The Resource, directed by Bruce Edwards, PhD and managed by Mark Carter, MS, provides cell analysis, cell sorting, and offline data analysis as standard services. Resource users are individually trained in instrument and software use. Current charge back rates to Resource users are in the low to mid-range of rates nationwide. The Resource also has a history of innovation: The Resource and members of the UNMCC Cancer Therapeutics (CT) Research Program (Sklar & B. Edwards) invented the capability to conduct high throughput screens using a flow cytometric platform (commercialized as HyperCyt in 2006), which led to creation of a full-fledged High Throughput Screening Center: The UNM Center for Molecular Discovery (CMD), which is affiliated with the Resource. In the past project period, the Resource has worked to facilitate access to CMD for UNMCC members as well as collaborators at other NCI Cancer Centers and HyperCyt high throughput screening as a technical service, allowing Resource users routine access to novel high throughput screening technologies. The Resource supports small scale screening projects for investigators who have already developed targets that are ready for screening in 96- or 384-well plates. The Resource also serves as a conduit for pilot projects funded from local resources to evolve into larger, NIH-supported screening projects in the CMD. This highly productive strategy has allowed UNMCC Program members to identify potent small molecule probes for estrogen receptors, GTPases, formyl peptide receptors and efflux transporters, as well as a number of approved drugs that could be repurposed for new clinical applications. The Resource also provides easily accessible reservation and billing systems. To promote excellence in research, the Resource provides UNMCC Program members and trainees with expert assistance and information to facilitate development of cell analysis and discovery projects in support of grant applications and publications. A Resource priority is to integrate advanced technologies developed by the CMD and UNMCC Research Programs into its operations to make them more broadly available to the research community. Education and dissemination activities include: participation in production of a UNM Shared Resource newsletter, workshops and presentations on specialized topics pertaining to flow cytometry and drug discovery, ad hoc facility tours for students and faculty, and a Resource web page to advertise upcoming events and Resource instruments, services and fees. During the previous 5-yr project period, 48 UNMCC members from 4 UNMCC Research Programs used the Resource, resulting in a total of 97 publications, of which 15 are presently pending PMCIDs. In the reporting year of July 2013 ? June 2014, UNMCC members were responsible for 86% of total Resource usage and were supported by 128 peer-reviewed grants.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA118100-15S9
Application #
10230655
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Ptak, Krzysztof
Project Start
2005-09-26
Project End
2021-08-31
Budget Start
2019-09-01
Budget End
2020-08-31
Support Year
15
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of New Mexico Health Sciences Center
Department
Type
DUNS #
829868723
City
Albuquerque
State
NM
Country
United States
Zip Code
87131
Kuehl, Philip J; Grimes, Marcie J; Dubose, Devon et al. (2018) Inhalation delivery of topotecan is superior to intravenous exposure for suppressing lung cancer in a preclinical model. Drug Deliv 25:1127-1136
Köbel, Martin; Luo, Li; Grevers, Xin et al. (2018) Ovarian Carcinoma Histotype: Strengths and Limitations of Integrating Morphology With Immunohistochemical Predictions. Int J Gynecol Pathol :
Bredemeyer, Andrea L; Edwards, Bruce S; Haynes, Mark K et al. (2018) High-Throughput Screening Approach for Identifying Compounds That Inhibit Nonhomologous End Joining. SLAS Discov 23:624-633
Orlow, Irene; Shi, Yang; Kanetsky, Peter A et al. (2018) The interaction between vitamin D receptor polymorphisms and sun exposure around time of diagnosis influences melanoma survival. Pigment Cell Melanoma Res 31:287-296
Sharma, Geetanjali; Mauvais-Jarvis, Franck; Prossnitz, Eric R (2018) Roles of G protein-coupled estrogen receptor GPER in metabolic regulation. J Steroid Biochem Mol Biol 176:31-37
Perez, Dominique R; Edwards, Bruce S; Sklar, Larry A et al. (2018) High-Throughput Flow Cytometry Drug Combination Discovery with Novel Synergy Analysis Software, SynScreen. SLAS Discov 23:751-760
Deretic, Vojo; Prossnitz, Eric; Burge, Mark et al. (2018) Autophagy, Inflammation, and Metabolism (AIM) Center of Biomedical Research Excellence: supporting the next generation of autophagy researchers and fostering international collaborations. Autophagy 14:925-929
Hill, Deirdre A; Friend, Sarah; Lomo, Lesley et al. (2018) Breast cancer survival, survival disparities, and guideline-based treatment. Breast Cancer Res Treat 170:405-414
Guo, Yan; Yu, Hui; Wang, Jing et al. (2018) The Landscape of Small Non-Coding RNAs in Triple-Negative Breast Cancer. Genes (Basel) 9:
Hatch, Ellen W; Geeze, Mary Beth; Martin, Cheyenne et al. (2018) Variability of PD-L1 expression in mastocytosis. Blood Adv 2:189-199

Showing the most recent 10 out of 344 publications